Publication Highlight: Psilocybin Prevents Chemotherapy-Induced Neuropathy by Preserving Mitochondrial Trafficking
Key Takeaways Two doses of psilocybin administered before chemotherapy prevented peripheral neuropathy in mice for up to eight months, without impairing the anti-tumor efficacy of the chemotherapy itself. The neuroprotective effect required serotonin 2A receptor activation but not the drug’s hallucinogenic properties. A nonhallucinogenic 2A agonist worked equally well, opening a practical path to clinical […]
